New drug combo aims to tame transplant complication
Disease control
Not yet recruiting
This phase 2 trial tests a combination of two oral drugs, ruxolitinib and belumosudil, for chronic graft-versus-host disease (cGvHD) that hasn't improved with steroids. cGvHD is a serious condition where donor immune cells attack the patient's body after a stem cell transplant. T…
Phase: PHASE2 • Sponsor: Dennis Kim • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC